CNP200137
/ CoBX Bio, Pharos iBio
- LARVOL DELTA
Home
Next
Prev
1 to 1
Of
1
Go to page
1
March 18, 2026
Discovery of CNP200137, a second-generation menin-MLL inhibitor with superior preclinical properties and anti-leukemic activity against acquired resistance
(AACR 2026)
- "Abstract is embargoed at this time."
Late-breaking abstract • Preclinical • Oncology
1 to 1
Of
1
Go to page
1